Jeong Seung-Hyun, Jang Ji-Hun, Jung Da-Hwa, Lee Guk-Yeo, Lee Yong-Bok
College of Pharmacy, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Korea.
Department of Korean Medicinal Resource Development, National Institute for Korean Medicine Development, Udae land gil 288, Jangheung, Jeollanamdo 59338, Korea.
Pharmaceutics. 2021 Apr 1;13(4):478. doi: 10.3390/pharmaceutics13040478.
The purpose of this study was to investigate the pharmacokinetic properties of ephedrine, paeoniflorin, and cinnamic acid after single or multiple doses of Socheongryong-tang (SCRT) were administered to rats, and to present an example of the pharmacokinetic changes following multiple doses of an herbal medicine. SCRT is a traditional herbal medicine that has been used clinically for a long time, and its main ingredients include ephedrine, paeoniflorin, and cinnamic acid. However, studies on the pharmacokinetic properties of SCRT are insufficient, and particularly, no pharmacokinetic information has been reported for multiple doses. In this study, SCRT was administered orally to rats once or multiple times, and plasma sampled at different times was quantitatively analyzed for ephedrine, paeoniflorin, and cinnamic acid using ultra-high-performance liquid chromatography-tandem mass spectrometry. There was a difference between the pharmacokinetic parameter values of each component (especially in paeoniflorin and cinnamic acid) obtained after single or multiple doses of SCRT. The actual observed values of each component obtained after multiple doses of SCRT were clearly different from the predicted results of multiple-dose simulations based on the pharmacokinetic profiles obtained after a single dose. The results confirmed that the plasma concentrations and, thus, exposures to paeoniflorin and cinnamic acid were significantly increased when SCRT was administered multiple times, whereas that of ephedrine was not. The results of this study are expected to provide useful pharmacokinetic data for the safety and efficacy evaluation of SCRT in the future and demonstrate the necessity of pharmacokinetic comparison studies according to single or multiple oral administrations of herbal medicines.
本研究旨在探讨给大鼠单次或多次给予芍姜萸楝汤(SCRT)后麻黄碱、芍药苷和肉桂酸的药代动力学特性,并给出多次服用草药后药代动力学变化的实例。SCRT是一种长期临床应用的传统草药,其主要成分包括麻黄碱、芍药苷和肉桂酸。然而,关于SCRT药代动力学特性的研究并不充分,尤其是多次给药的药代动力学信息尚未见报道。在本研究中,对大鼠单次或多次口服SCRT,使用超高效液相色谱-串联质谱法定量分析不同时间采集的血浆中麻黄碱、芍药苷和肉桂酸的含量。单次或多次给予SCRT后各成分(尤其是芍药苷和肉桂酸)的药代动力学参数值存在差异。多次给予SCRT后各成分的实际观测值与基于单次给药后药代动力学曲线进行的多剂量模拟预测结果明显不同。结果证实,多次给予SCRT时,芍药苷和肉桂酸的血浆浓度及暴露量显著增加,而麻黄碱则不然。本研究结果有望为未来SCRT的安全性和有效性评价提供有用的药代动力学数据,并证明根据草药单次或多次口服进行药代动力学比较研究的必要性。